hematopoietic malignancy

he·ma·to·poi·et·ic ma·lig·nan·cy

(hēmă-tō-poy-etik mă-lignăn-sē)
Cancer of the blood-forming organs caused by stem cell mutation.

hematopoietic malignancy

Any of the cancers that arise from unregulated clonal proliferation of hematopoietic stem cells, such as leukemia and lymphoma. In these disorders, genetically abnormal blood-forming cells (derived from precursors of granulocytes, lymphocytes, platelets, or red blood cells) reproduce in an unchecked fashion, consume nutrients, infiltrate various tissues, and replace the body's normally functioning cells.
See: leukemia; lymphoma
References in periodicals archive ?
Specifically, significant performance differences were found in concordance rates between pathologists and cytotechnologists for diagnoses of leukemia/lymphoma/other hematopoietic malignancy, acute and chronic inflammation, and small blue round cell tumors (nonhematopoietic).
The most common incorrect diagnoses for the acute or chronic inflammation/reactive category were hematopoietic malignancy and fungal infection.
The hematopoietic malignancy challenges in the CAP NGC tend to have large numbers of malignant cells.
We report our preliminary experience in using rFVIIa among hematopoietic malignancy patients suffering from uncontrolled GI bleeding after HSCT.
* Before making a decision regarding the use of ESAs, an appropriate history, physical examination, and diagnostic tests should be conducted to identify alternative causes of anemia aside from chemotherapy or an underlying hematopoietic malignancy.
William Tse, M.D., has joined the Mary Babb Randolph Cancer Center as the co-leader of the Osborn Hematopoietic Malignancy and Transplantation Program, the state's only source for blood and marrow transplants.
Smoking was not associated with any hematopoietic malignancy and did not appear to confound the association between radon and leukemia.
With time, however, I believe they will realize that hematopoietic malignancy usually presents with unexplained alterations in cell counts.
For lymphoma or hematopoietic malignancy cases, modified Giemsa slides had the highest concordance rates for all fluids, which further emphasizes the importance of performing a modified Giemsa stain on cases with potential lymphoma or other hematopoietic disease involvement.
The Wnt signaling pathway is involved in both hematopoietic malignancy and colon carcinoma.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematopoietic malignancy derived from the precursors of plasmacytoid dendritic cells.

Full browser ?